WHO ICTRP trial
Self-administered fentanyl for birthing women.
ACTRN12609000006246 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12609000006246 |
|---|---|
| Public title | Self-administered fentanyl for birthing women. |
| Scientific title | An evaluation of the safety and effectiveness of patient-controlled intranasal fentanyl for relieving pain in birthing women. |
| Primary sponsor | Western Health |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Australia |
| Conditions | Childbirth; Childbirth;Reproductive Health and Childbirth - Childbirth and postnatal care |
| Interventions | This is a non-comparative study. Participants will self-administer intranasal fentanyl during childbirth as a form of analgesia. Non-comparative study. It is expected that the use of intranasal fentanyl during childbrth will enhance the… |
| Registration date | Jun 1, 2009 |
| Target size | 50 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: